The commission shall:
- (1) monitor and analyze Medicaid prescription drug use and expenditure patterns;
- (2) identify the therapeutic prescription drug classes and individual prescription drugs that are most often prescribed to patients or that represent the greatest expenditures; and
- (3) post the data the commission identifies under this section on the commission's Internet website and update the information on a quarterly basis.
Added by Acts 2023, 88th Leg., R.S., Ch. 769 (H.B. 4611), Sec. 1.01, eff. April 1, 2025.